BioXcel Seeks OK For $9.8M Deal With Investors
By Emlyn Cameron · October 29, 2026, 4:48 PM EDT
Artificial intelligence-powered pharmaceutical group BioXcel has asked a Delaware bankruptcy judge to sign off on a $9.75 million settlement between the debtor and plaintiffs in a securities class action against it,...
To view the full article, register now.